نتایج جستجو برای: chronic obstructive pulmonary
تعداد نتایج: 704429 فیلتر نتایج به سال:
Abbreviations: chronic obstructive pulmonary disease, COPD; quality adjusted life years, QALYs; forced expiratory volume in 1 second, FEV1; forced vital capacity, FVC Citation: Pinnock H, Sohanpal R. Editorial-Chronic obstructive pulmonary disease: reduced nihilism, but there is still a ways to go. Chronic Obstr Pulm Dis (Miami). 2016; 3(3): 605-609. doi: http://dx.doi.org/10.15326/jcopdf.3.3.2...
Background & Aims : Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow obstruction. Many of the systemic manifestations of chronic obstructive pulmonary disease are mediated through increased systemic levels of inflammatory proteins. Oxidative stress and inflammation are the major hallmarks of COPD and inflammatory factors can be used as a biomarker to asses...
Pulmonary hypertension (PH) is an important cause of heart failure in chronic obstructive pulmonary disease (COPD). The pro brain natriuretic peptide N-terminal (NT-proBNP) has been suggested as a noninvasive marker to evaluate ventricular function. However, there is no evidence to support the use of NT-proBNP in monitoring the benefits of vasodilators in COPD induced PH. Thus, we used NT-proBN...
Chronic Obstructive Pulmonary Disease (COPD) is characterized by irreversible airflow limitation in the lungs. COPD frequently coexist with Heart Failure (HF) but most patients go undiagnosed because of similarity symptoms. Data on prevalence HF are discrepant and scarce.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by irreversible airflow limitation in the lungs. COPD frequently coexist with Heart Failure (HF) but most patients go undiagnosed because of similarity symptoms. Data on prevalence HF are discrepant and scarce.
Chronic Obstructive Pulmonary Disease (COPD) is characterized by irreversible airflow limitation in the lungs. COPD frequently coexist with Heart Failure (HF) but most patients go undiagnosed because of similarity symptoms. Data on prevalence HF are discrepant and scarce.
tive pulmonary disease. N Engl J Med 2000; 343:1902–1909 10 Paggiaro PL, Dahle R, Bakran I, et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351:773–780 11 Mahler DA, Wire P, Horstman D, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus de...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید